Yuan-Hao Lee
Overview
Explore the profile of Yuan-Hao Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lai D, Chu P, Sheu M, Tsai Y, Lee Y, Liu S, et al.
Phytomedicine
. 2024 Dec;
136():156249.
PMID: 39616730
Background: Oral cancer is a malignant tumor of the oral cavity, with regulatory T cell (Treg) infiltration associated with poor prognosis. Ginkgolide B (GB) has demonstrated effects on lipid metabolism;...
2.
Lin Y, Mo J, Zeng H, Lee Y
Radiat Res
. 2024 Jan;
201(3):197-205.
PMID: 38289696
Proton therapy has been widely applied on treating inaccessible and inoperable tumors, such as tumors deep within the brain or close to the critical brain stem. Nevertheless, the damaging effect...
3.
Tsai P, Liu Y, Li T, Hsu F, Lee Y, Chiang I, et al.
In Vivo
. 2023 Oct;
37(6):2776-2785.
PMID: 37905662
Background/aim: Radiation therapy (RT) for head and neck cancer may cause severe radiation dermatitis (RD) resulting in RT interruption and affecting disease control. A few studies address skin moisture changes...
4.
Lee Y, Kothmann W, Lin Y, Chuang A, Diamond J, OBrien J
eNeuro
. 2023 Aug;
10(8).
PMID: 37527925
Synaptic plasticity is a fundamental feature of the CNS that controls the magnitude of signal transmission between communicating cells. Many electrical synapses exhibit substantial plasticity that modulates the degree of...
5.
Li C, Ku M, Lee K, Yueh P, Hsu F, Lin R, et al.
Anticancer Res
. 2022 Aug;
42(9):4403-4410.
PMID: 36039427
Background/aim: Osteosarcoma is an aggressive primary malignant bone tumor that occurs in childhood. Although the diagnostic and treatment options have been improved, osteosarcoma confers poor prognosis. Magnolol, an active component...
6.
Chiang I, Lee Y, Tan Z, Hsu F, Tu H
Biomed Pharmacother
. 2022 Jan;
147:112661.
PMID: 35092865
Oral squamous cells carcinoma (OSCC) is the most common oral malignancy that majorly originated from oral cavity. Though the prognostic and predictive value of targeting checkpoint molecules has been reported...
7.
Yueh P, Lee Y, Fu C, Tung C, Hsu F, Lan K
Life (Basel)
. 2021 Dec;
11(12).
PMID: 34947930
Glioblastoma multiforme (GBM) is the most common form of malignant brain tumor, with poor prognosis; the efficacy of current standard therapy for GBM remains unsatisfactory. Magnolol, an herbal medicine from...
8.
Wu C, Hsu F, Chao T, Lee Y, Kuo Y
Biomed Pharmacother
. 2021 Dec;
145:112437.
PMID: 34864311
Nuclear factor-kappa B (NF-κB), an oncogenic transcription factor, modulates tumor formation and progression by inducing the expression of oncogenes involved in proliferation, survival, angiogenesis, and metastasis. Oral multikinase inhibitors, such...
9.
Yueh P, Lee Y, Chiang I, Chen W, Lan K, Chen C, et al.
Front Oncol
. 2021 Nov;
11:735183.
PMID: 34765548
Background: Anti-depressants have been reported to own anti-tumor potential types of cancers; however, the role of imipramine in non-small cell lung cancer (NSCLC) has not been elucidated. Epidermal growth factor...
10.
Ko C, Lee S, Hsieh Y, Lee Y, Yao M, Chan W
Medicine (Baltimore)
. 2021 Jun;
100(25):e26277.
PMID: 34160391
Background: Radiosensitivity in the breasts increases the risk of carcinogenesis from exposure to the ionizing radiation of computed tomography (CT) administered in the course of medical attention. Bismuth shielding techniques...